Company Profiles

driven by the PitchBook Platform

Remedy Pharmaceuticals

Description

Developer of small molecule drugs designed to help people with central nervous system related edema for surviving life to the fullest. The company's small molecule drugs including CIRARA, target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries, enabling patients with central nervous system disorders to lead a healthy life.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$9M

Latest Deal Amount

$15.3M

Total Amount Raised

Description

Developer of small molecule drugs designed to help people with central nervous system related edema for surviving life to the fullest. The company's small molecule drugs including CIRARA, target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries, enabling patients with central nervous system disorders to lead a healthy life.

Website:

www.remedypharmaceuticals.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

233 Broadway 17th Floor New York, NY 10279United States +1 (212) 586-2226
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Remedy Pharmaceuticals's full profile, request a free trial.

    Remedy Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Remedy Pharmaceuticals Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
    Broadview VenturesVenture CapitalMinority000 0000000 0000
    Carrot Capital Healthcare VenturesVenture CapitalMinority000 0000000 0000
    Edgar S. WoolardAngel (individual)Minority000 0000000 0000
    Eric A. PottsAngel (individual)Minority000 0000000 0000
    Biosciences Research and Commercialization Center Venture Capital
    Broadview Ventures Venture Capital
    Carrot Capital Healthcare Ventures Venture Capital
    Edgar S. Woolard Angel (individual)
    Eric A. Potts Angel (individual)

    Remedy Pharmaceuticals Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Richard SteinhartChief Financial Officer
    Thomas MacAllister JDVice President, Research & Development & General Counsel
    Ann Tunstall Ph.DVice President, Regulatory And Clinical Operations
    Sven JacobsonCo-Founder, Chief Executive Officer & Board Member
    Richard Steinhart Chief Financial Officer
    Thomas MacAllister JD Vice President, Research & Development & General Counsel
    Ann Tunstall Ph.D Vice President, Regulatory And Clinical Operations
    Sven Jacobson Co-Founder, Chief Executive Officer & Board Member

    Remedy Pharmaceuticals Board Members (10)

    NameRepresentingRoleSinceContact
    Info
    Charles MeleRemedy PharmaceuticalsBoard Member & Advisor000 0000
    David EpsteinRemedy PharmaceuticalsBoard Member000 0000
    David GeliebterCarrot Capital Healthcare VenturesManaging Director & Senior Partner000 0000
    Edgar WoolardRemedy PharmaceuticalsBoard Member000 0000
    Eric Potts MDRemedy PharmaceuticalsBoard Member000 0000
    Charles Mele Board Member & Advisor Remedy Pharmaceuticals
    David Epstein Board Member Remedy Pharmaceuticals
    David Geliebter Managing Director & Senior Partner Carrot Capital Healthcare Ventures
    Edgar Woolard Board Member Remedy Pharmaceuticals
    Eric Potts MD Board Member Remedy Pharmaceuticals
    Request full access to PitchBook